Found: 17
Select item for more details and to access through your institution.
Basal insulin secretion capacity predicts the initial response and maximum levels of beta‐hydroxybutyrate during therapy with the sodium‐glucose co‐transporter‐2 inhibitor tofogliflozin, in relation to weight loss.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 222, doi. 10.1111/dom.13890
- By:
- Publication type:
- Article
Fournier's gangrene and sodium‐glucose co‐transporter‐2 inhibitors: A meta‐analysis of randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 272, doi. 10.1111/dom.13900
- By:
- Publication type:
- Article
Comparative cardiovascular and hypoglycaemic safety of glimepiride in type 2 diabetes: A population‐based cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 254, doi. 10.1111/dom.13893
- By:
- Publication type:
- Article
Optimal fasting glucose levels with regard to cardiovascular and mortality outcomes in people treated with or without antidiabetic medication.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 243, doi. 10.1111/dom.13892
- By:
- Publication type:
- Article
Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 231, doi. 10.1111/dom.13891
- By:
- Publication type:
- Article
Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 212, doi. 10.1111/dom.13889
- By:
- Publication type:
- Article
Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 203, doi. 10.1111/dom.13888
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of rongliflozin, a novel selective inhibitor of sodium‐glucose co‐transporter‐2, in people with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 191, doi. 10.1111/dom.13887
- By:
- Publication type:
- Article
Fournier's gangrene in patients with type 2 diabetes using second‐line antidiabetic medications.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 267, doi. 10.1111/dom.13886
- By:
- Publication type:
- Article
Risk of first stroke in people with type 2 diabetes and its relation to glycaemic control: A nationwide observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 182, doi. 10.1111/dom.13885
- By:
- Publication type:
- Article
Efficacy of metformin in preventing progression to diabetes in a Chinese population with impaired glucose regulation: Protocol for a multicentre, open‐label, randomized controlled clinical study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 158, doi. 10.1111/dom.13884
- By:
- Publication type:
- Article
Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open‐label, active‐controlled, 12‐week study (STABLE II study).
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 173, doi. 10.1111/dom.13882
- By:
- Publication type:
- Article
Primary versus secondary cardiorenal prevention in type 2 diabetes: Which newer anti‐hyperglycaemic drug matters?
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 149, doi. 10.1111/dom.13881
- By:
- Publication type:
- Article
Trends in antidiabetic drug utilization and expenditure in Denmark: A 22‐year nationwide study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 167, doi. 10.1111/dom.13877
- By:
- Publication type:
- Article
Effects of sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes in women versus men.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 263, doi. 10.1111/dom.13876
- By:
- Publication type:
- Article
Mechanism of glucose‐lowering by metformin in type 2 diabetes: Role of bile acids.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 141, doi. 10.1111/dom.13869
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 139, doi. 10.1111/dom.13713
- Publication type:
- Article